The FDA has approved Johnson & Johnson’s Tremfya to treat adults with moderate to severe ulcerative colitis.
FDA approves Johnson & Johnson GI treatment
The FDA has approved Johnson & Johnson’s Tremfya to treat adults with moderate to severe ulcerative colitis.